Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011791 |
---|---|
Receipt number | R000013786 |
Scientific Title | A phase II study of Erlotinib and Bevacizumab combination therapy for previously treated III B / IV Stage non-squamous non-small cell lung cancer: IMSLC-001 |
Date of disclosure of the study information | 2013/09/18 |
Last modified on | 2013/09/18 13:54:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/09/18 13:55:20 |